Comparison of the effectiveness of medications containing a combination of zinc and arginine for treatment of male infertility

Author:

Zhukov О. B.1ORCID,Bragina E. E.2ORCID,Levina A. V.3ORCID,Evdokimov V. V.4ORCID,Terushkin R. A.5ORCID,Akramov M. M.6ORCID,Shakhov A. S.7ORCID,Vasilyev A. E.8ORCID

Affiliation:

1. RUDN University; Association of Vascular Urologists and Reproductologists

2. A.N. Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University; N.P. Bochkov Research Centre for Medical Genetics

3. Institute of Toxicology, Federal Medical and Biological Agency of Russia

4. N.А. Lopatkin Scientific Research Institute of Urology and Interventional Radiology – branch of the National Medical Research Radiologiсal Center, Ministry of Health of Russia

5. Clinic of Professor Kalinchenko

6. RUDN University

7. A.N. Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University

8. National Research Center for Hematology

Abstract

The study objective is to perform clinical laboratory evaluation of the effectiveness of Prostatilen® AC and Arginine-zinc in treatment of patients with sperm pathology and concomitant varicocele and chronic nonbacterial prostatitis.Materials and methods. The study included 60 patients between 23 and 46 years of age. The first group included 30 patients (15 patients with varicocele and 15 patients with chronic nonbacterial prostatitis) who received Prostatilen® AC. The second group included 30 patients (15 patients with varicocele and 15 patients with chronic nonbacterial prostatitis) who received Arginine-zinc. Therapy duration was 20 days. Standard clinical and laboratory examination, spermiologic examination as well as measurement of antisperm antibodies, DNA fragmentation, oxidative stress level, cryotest, electron microscopy examination of the ejaculate were performed.Results. Five (5) days after the end of therapy, percentage of progressive motile sperm increased by 62 % in the Prostatilen® AC patient group with chronic nonbacterial prostatitis (р <0.001) compared to the baseline, and by only 10 % in the Arginine-zinc patient group. Administration of Prostatilen® AC lead to a more significant decrease of reactive oxygen intermediates in the ejaculate (р <0.001) and percentage of sperm with fragmented DNA (р <0.001) compared to administration of Arginine-zinc. The applied treatment schemes had no significant effect on the number of sperm with acrosomal hypoplasia. An anti-inflammatory effect of Prostatilen® AC was also identified (decreased number of leukocytes in sperm). During the study, 3 cases of adverse effects were registered: 1 after administration of Prostatilen® AC and 2 after administration of Arginine-zinc.Conclusion. Prostatilen® AC can be considered more effective and safer compared to Arginine-zinc for 20-day administration. In patients with sperm pathology, it more effectively improves sperm characteristics: increases sperm motility, sperm morphology, decreases DNA fragmentation and oxidative stress levels.

Publisher

Publishing House ABV Press

Subject

Urology,Reproductive Medicine,Surgery

Reference20 articles.

1. Zegers-Hochschild F., Adamson G.D., Dyer S. et al. The International Glossary on Infertility and Fertility Care, 2017. Fertil Steril 2017;108(3):393–406. DOI: 10.1016/j.fertnstert.2017.06.005.

2. WHO manual for the standardized investigation and diagnosis of the infertile couple. Cambridge: Cambridge University Press, 2000.

3. Agarwal A., Mulgund A., Hamada A., Chyatte M.R. A unique view on male infertility around the globe. Reprod Biol Endocrinol 2015;13:37. DOI: 10.1186/s12958-015-0032-1.

4. Filippov O.S. Causes and factors of infertility among the population of Siberia. Epidemiologiya i infektsionnye bolezni = Epidemiology and Infectious Diseases 2002;(3):47–9. (In Russ.).

5. Ustinova T.A., Artimuk N.V., Vlasova V.V., Pyshov A.Y. Infertility in couples of Kemerovo Region. Mat i ditya v Kuzbasse = Mother and baby in Kuzbass 2010;(1):37–9. (In Russ.).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3